Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT

Marker Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.6 -5.88 -0.74 -1.74
PEG Ratio
0.07 0.13 0.02 0.17
PS Ratio
4.24 14.63 2.47 58.53
PB Ratio
0.00 3.45 1.13 1.65
P/FCF Ratio
-2.56 -2.95 -0.7 -2.39
P/OCF Ratio
-2.56 -2.95 -0.82 -2.66
OCF/S Ratio
-1.66 -4.97 -3 -21.96
Debt / Equity Ratio
n/a n/a 0.39 0.27
Quick Ratio
6.36 5.89 2.14 3.56
Current Ratio
6.36 5.57 2.14 3.56
Asset Turnover
0.30 0.19 0.26 0.02
Interest Coverage
n/a n/a n/a n/a
Return on Equity
n/a -0.59 -1.53 -0.95
Return on Assets
-0.49 -0.48 -0.87 -0.61
Return on Invested Capital
-0.6 -1.04 -0.73 -0.7
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-1.04 -2.15 0.59 -1.55
Net Profit Margin
-1.63 -2.49 -3.32 -33.72
Pretax Profit Margin
-1.62 -4.24 -2.2 -33.72
Operating Profit Margin
-1.69 -4.4 -2.2 -31.79
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.69 -3.4 -2.2 -29.24